Clinical Observation of Integrated Chinese Medicine With Western Medicine for the Reduction of Chemotherapy-induced Hematologic Toxicity

Myelosuppression Clinical Trial

Official title:
Clinical Observation of Integrated Chinese Medicine With Western Medicine for the Reduction of Chemotherapy-induced Hematologic Toxicity

Status Completed

Clinical Trial Summary

We conducted an observational study to investigate the effectiveness and safety of Integrated Chinese Medicine With Western Medicine for bone marrow suppression induced by chemotherapy in patients with cancer. The TCM constitution and pulse diagnosis was also observed in the study.

Clinical Trial Description

Patients with cancer under chemotherapy and integrated Western and Chinese medicine were enrolled in this observational study. The assessment of radial pressure pulse (RPP) was performed before and after chemotherapy. The correlation between the spectral energy (SE0-10 Hz, SE10-50 Hz, and SE13-50 Hz) of the RPP at six diagnosis positions and the blood cell counts before and after chemotherapy were analyzed. ;

Study Design

Related Conditions & MeSH terms

Myelosuppression

Clinical Trial Details

NCT number	NCT05442177
Study type	Observational
Source	Taichung Tzu Chi Hospital
Contact
Status	Completed
Phase
Start date	July 1, 2015
Completion date	June 30, 2016

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT00524797` - Profonycia - Honey for Improving Quality of Patient's Life Receiving Chemotherapy	N/A
Completed	`NCT00151866` - Efficacy of Transfusions With Platelets Stored in Platelet Additive Solution II Versus Plasma	Phase 3
Recruiting	`NCT03126890` - Investigation of the Correlation Between Plasma Concentration of Linezolid Antibiotic and Treatment Response and Adverse Reactions
Completed	`NCT02692742` - Efficacy and Safety Phase IIa Study of Myelo001 in Chemotherapy-Induced Neutropenia	Phase 2
Terminated	`NCT02375334` - Adherence Monitoring System in Managing Myelosuppression in Patients With Newly Diagnosed Malignant Gliomas Receiving Temozolomide and Radiation Therapy
Not yet recruiting	`NCT03846414` - Real World Study of PEG-rhG-CSF in Prevention of Chemotherapy-induced Neutropenia
Recruiting	`NCT04905329` - A Multicenter Prospective Post-registration Study of Empegfilgrastim to Evaluate Safety and Efficacy in Special Cancer Populations
Not yet recruiting	`NCT05780294` - A Multi-center, Randomized, Double-blind, Phase III Clinical Trial of Leucogen Versus Placebo on Leukocyte and Platelet Whole-course Management Assisted by PFLL Chemotherapy in the Treatment of Stage IV, Recurrent or Metastatic NPC	Phase 3